Glucocorticoid
A class of steroid hormones (cortisol) and synthetic drugs (prednisone, dexamethasone) that suppress inflammation and immune responses. Glucocorticoids are among the most commonly prescribed drugs in veterinary medicine, with significant benefits and risks.
Glucocorticoids are steroid hormones produced naturally by the adrenal cortex (cortisol) and available as synthetic drugs (prednisone, prednisolone, dexamethasone, methylprednisolone, budesonide). They are among the most prescribed medications in veterinary medicine due to their potent anti-inflammatory and immunosuppressive effects.
Mechanism of Action
Glucocorticoids enter cells and bind to intracellular glucocorticoid receptors. The activated receptor complex translocates to the nucleus and modifies gene expression — upregulating anti-inflammatory genes and downregulating pro-inflammatory cytokine production (IL-1, IL-6, TNF-alpha). They also stabilize cell membranes, reduce vascular permeability, and suppress immune cell activation and migration.
This broad mechanism explains both their therapeutic versatility and their wide-ranging side effects.
Common Veterinary Uses
Anti-inflammatory (low to moderate doses): Atopic dermatitis, arthritis, inflammatory bowel disease, allergic reactions, asthma.
Immunosuppressive (high doses): Immune-mediated hemolytic anemia (IMHA), immune-mediated thrombocytopenia (ITP), meningoencephalitis, pemphigus.
Replacement therapy: Addison’s disease (hypoadrenocorticism) requires lifelong physiological-dose glucocorticoid replacement because the adrenal glands cannot produce adequate cortisol.
Oncology: Prednisone is part of multi-agent chemotherapy protocols for lymphoma and other cancers, and is used as palliative monotherapy.
Side Effects
Glucocorticoid side effects are dose- and duration-dependent:
Short-term: Increased thirst and urination (polydipsia/polyuria), increased appetite, panting, restlessness, GI upset.
Long-term: Muscle wasting, skin thinning, poor wound healing, hepatopathy (steroid hepatopathy elevates alkaline phosphatase), predisposition to urinary tract infections, ligament and tendon weakening, iatrogenic Cushing’s disease (exogenous hypercortisolism).
Metabolic: Insulin resistance (risk of diabetes with chronic use), lipid metabolism disruption, negative calcium balance (bone density loss).
Glucocorticoids and the HPA Axis
Exogenous glucocorticoids suppress the hypothalamic-pituitary-adrenal (HPA) axis through negative feedback. After prolonged use, the adrenal glands atrophy and cannot produce adequate cortisol if the drug is abruptly discontinued. This is why glucocorticoids must always be tapered gradually — abrupt withdrawal risks adrenal crisis.
Relevance to Longevity
Glucocorticoids are life-saving drugs for immune-mediated diseases and acute inflammatory emergencies. However, chronic use carries significant longevity implications. Evidence-based strategies to minimize long-term risk include using the lowest effective dose, employing steroid-sparing agents (azathioprine, mycophenolate, cyclosporine) for chronic conditions, choosing locally-acting formulations (budesonide for GI disease) when possible, and pursuing definitive diagnoses to avoid indefinite empirical steroid use.